Laparoscopic vs open surgery for gastric cancer: Assessing time, recovery, complications, and markers

Table 1 Clinical data

Factors	Control group (n = 90)	Observation group (n = 104)	χ2 value	P value
Sex			0.335	0.562
Male	59	64
Female	31	40
Age (yr)			0.533	0.465
≥ 60	48	50
< 60	42	54
BMI (kg/m2)			0.359	0.548
≥ 25	25	33
< 25	65	71
ASA score			2.300	0.129
Phase II	44	35
Phase III	56	69
History of abdominal surgery			1.218	0.269
Yes	12	20
No	78	84
Medical history
Hypertension	28	35	0.142	0.706
Diabetes mellitus	19	27	0.627	0.428

Table 2 Clinical efficacy evaluation

Group	Control group (n = 90)	Observation group (n = 104)	χ2 value	P value
Markedly effective	40 (44.44)	70 (67.31)	10.656	0.001
Effective	32 (35.56)	34 (32.69)
Ineffective	18 (20.00)	5 (4.81)
Total effective rate	72 (20.00)	99 (95.19)

Table 3 Complications

Group	Control group (n = 90)	Observation group (n = 104)	χ2 value	P value
Subcutaneous emphysema	8	1	13.36	< 0.001
Incision infection	4	3
Ileus	4	2
Seroperitoneum	5	2
Anastomotic leakage	5	1
Total incidence rate	26 (28.89%)	9 (8.65%)

Table 4 Comparison of recurrence and survival rates

Group	Control group (n = 90)	Observation group (n = 104)	χ2 value	P value
3-year survival rate	64 (71.11)	73 (69.23)	0.081	0.775
3-year recurrence rate	14 (15.56)	18 (17.31)	0.107	0.743